VolitionRx Limited

NYSEAM:VNRX Stock Report

Market Cap: US$73.2m

VolitionRx Management

Management criteria checks 3/4

VolitionRx's CEO is Cameron Reynolds, appointed in Jan 2010, has a tenure of 14.33 years. total yearly compensation is $772.93K, comprised of 50.6% salary and 49.4% bonuses, including company stock and options. directly owns 1.56% of the company’s shares, worth $1.14M. The average tenure of the management team and the board of directors is 3.3 years and 5 years respectively.

Key information

Cameron Reynolds

Chief executive officer

US$772.9k

Total compensation

CEO salary percentage50.6%
CEO tenure14.3yrs
CEO ownership1.6%
Management average tenure3.3yrs
Board average tenure5yrs

Recent management updates

Recent updates

Do Institutions Own VolitionRx Limited (NYSEMKT:VNRX) Shares?

Mar 17
Do Institutions Own VolitionRx Limited (NYSEMKT:VNRX) Shares?

This Insider Has Just Sold Shares In VolitionRx Limited (NYSEMKT:VNRX)

Feb 10
This Insider Has Just Sold Shares In VolitionRx Limited (NYSEMKT:VNRX)

Market Sentiment Around Loss-Making VolitionRx Limited (NYSEMKT:VNRX)

Jan 27
Market Sentiment Around Loss-Making VolitionRx Limited (NYSEMKT:VNRX)

Have Insiders Been Selling VolitionRx Limited (NYSEMKT:VNRX) Shares This Year?

Dec 29
Have Insiders Been Selling VolitionRx Limited (NYSEMKT:VNRX) Shares This Year?

What Type Of Shareholders Own The Most Number of VolitionRx Limited (NYSEMKT:VNRX) Shares?

Nov 30
What Type Of Shareholders Own The Most Number of VolitionRx Limited (NYSEMKT:VNRX) Shares?

CEO Compensation Analysis

How has Cameron Reynolds's remuneration changed compared to VolitionRx's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$773kUS$391k

-US$35m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$33m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$761kn/a

-US$30m

Sep 30 2022n/an/a

-US$31m

Jun 30 2022n/an/a

-US$30m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021US$982kn/a

-US$27m

Sep 30 2021n/an/a

-US$24m

Jun 30 2021n/an/a

-US$21m

Mar 31 2021n/an/a

-US$21m

Dec 31 2020US$563kUS$364k

-US$20m

Sep 30 2020n/an/a

-US$19m

Jun 30 2020n/an/a

-US$19m

Mar 31 2020n/an/a

-US$18m

Dec 31 2019US$518kUS$391k

-US$16m

Sep 30 2019n/an/a

-US$17m

Jun 30 2019n/an/a

-US$17m

Mar 31 2019n/an/a

-US$18m

Dec 31 2018US$660kUS$398k

-US$18m

Sep 30 2018n/an/a

-US$18m

Jun 30 2018n/an/a

-US$17m

Mar 31 2018n/an/a

-US$16m

Dec 31 2017US$690kUS$294k

-US$15m

Compensation vs Market: Cameron's total compensation ($USD772.93K) is about average for companies of similar size in the US market ($USD667.96K).

Compensation vs Earnings: Cameron's compensation has increased whilst the company is unprofitable.

CEO

Cameron Reynolds (52 yo)

14.3yrs

Tenure

US$772,933

Compensation

Mr. Cameron Reynolds, MBA, founded VolitionRX in 2010 and has been its President, Chief Executive Officer and Director since October 6, 2011. Mr. Reynolds has been Independent Non-Executive Director of Pat...

Leadership Team

NamePositionTenureCompensationOwnership
Martin Faulkes
Executive Chairman12.6yrsUS$317.31k1.94%
$ 1.4m
Cameron Reynolds
Founder14.3yrsUS$772.93k1.56%
$ 1.1m
Gaetan Michel
Chief Operating Officer3.3yrsUS$667.81k0.059%
$ 43.0k
Salvatore Butera
Chief Executive Officer of Volition Veterinary Diagnostics Development LLC3yrsUS$619.79k0.27%
$ 196.0k
Terig Hughes
CFO & Treasurer3.3yrsUS$513.23k0.060%
$ 43.7k
Jacob Micallef
Chief Scientific Officer9.3yrsUS$657.89k0.32%
$ 235.3k
Nicholas Plummer
Group General Counsel2.5yrsno data0.073%
$ 53.2k
Louise Batchelor Day
Group Chief Marketing & Communications Officer8.1yrsno data0.068%
$ 49.4k
Thomas Bygott
Sales & Marketing Directorno datano datano data
Gael Forterre
Chief Commercial Officer3.3yrsno data0.093%
$ 68.2k
Sharon Ballesteros
U.S. Head of Quality & Development Process2.1yrsno datano data
Andrew Retter
Chief Medical Officerless than a yearno datano data

3.3yrs

Average Tenure

52yo

Average Age

Experienced Management: VNRX's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Martin Faulkes
Executive Chairman12.6yrsUS$317.31k1.94%
$ 1.4m
Cameron Reynolds
Founder12.6yrsUS$772.93k1.56%
$ 1.1m
Edward Futcher
Independent Non-Executive Director7.9yrsUS$61.94k0.075%
$ 55.2k
Guy Innes
Lead Independent Director12.6yrsUS$63.14k2.72%
$ 2.0m
Mickie Henshall
Independent Director1.8yrsUS$2.22k0.014%
$ 10.0k
Mark Eccleston
Member of Scientific Advisory Boardless than a yearUS$252.77kno data
Phillip Barnes
Independent Non-Executive Director4.6yrsUS$61.94k0.018%
$ 13.1k
Alan Colman
Chairman of Scientific Advisory Board & Independent Non Executive Director12.6yrsUS$86.00k0.20%
$ 149.9k
Axel Imhof
Member of Scientific Advisory Board5.3yrsno datano data
Kim Nguyen
Independent Director3.2yrsUS$63.14k0.070%
$ 51.4k
Timothy Fan
Member of Scientific Advisory Board2.3yrsno datano data
Alexander Hoffmann
Member of Scientific Advisory Board1.3yrsno datano data

5.0yrs

Average Tenure

60yo

Average Age

Experienced Board: VNRX's board of directors are considered experienced (5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.